Atlas Trials

Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central Cornea

Clinical trial NCT01057147 · COMPLETED

Trial details

NCT number
NCT01057147
Sponsor
Kubota Vision Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Keratoconjunctivitis SiccaDry Eye
Start date
2010-02-01
Primary completion
2011-01-01
Enrollment
116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.